Ivana Szady – Marketing Communications Manager, North Shore InnoVentures Q: How would you describe what InnoVentures does? Ivana: I try to explain how excellent it is that somebody with a good idea and a business plan can come into a lab situation and be able to share equipment and resources provided by InnoVenutres, whether it’sRead more
Blog
Jon Levenson, CSO – FireCyte Therapeutics Q: What does FireCyte Therapeutics do? Jon: We are a brand-new, startup, neuro ophthalmology biotech and we are focused on coming up with novel, therapeutic strategies for degenerative diseases of the retina, like glaucoma. We’re focused on the processes of neuroinflammation and the cells that mediate that phenomenon microglia.Read more
Shannon Johnson – Founder, Merida SkinLabs Q: Could you tell me a little about yourself and Merida Skin? Shannon: Merida Skin is a clean, clinical skin care brand that arose as the solution to my own Rosacea struggle. A big part of what we’re doing right now is that we have products that have passedRead more
New Members, new events, a new seal…Read more
Tom Kinneman, COO/VP – North Shore InnoVentures Q: How did you end up working at InnoVentures? Tom: I’m originally an engineer. I started in research, and helped develop some new technology that I took to the marketplace and implement in the real world. I found that second part a lot more fun than inventing things,Read more
January 11, 2021 11:00 AM (Eastern Standard Time) BEVERLY, MA (Scipreneur) Adeptrix Corp, the developer of advanced bioanalytical tools based on its proprietary BAMS™ (Bead Assisted Mass Spectrometry) platform technology, today announced the closing of its Series A investment round with Bruker Corporation as a new minority investor. The proceeds will go toward accelerating commercializationRead more
Spectrus creates technology to connect doctors and patients in Peru, where CSO Dr. Enrique Arevalo grew up and is now making a positive impact. In the wake of the global COVID-19 pandemic, biotech companies both small and large are innovating in ways to manage the detection and treatment of this disease. NSIV member company SpectrusRead more
“Many of these new protocols are about establishing new habits,” said Fleming. As Massachusetts commences phase I of the Governor’s reopening plan, we plan to allow all of our members to access NSIV facilities while preventing infection between members, staff, and potential visitors. In order to do so, extensive disinfecting and social distancing precautions areRead more
CEO of Thrive Bioscience, Tom Farb-Horch, delivers his thoughts on the best company strategy, stakeholder engagement, and personal demeanor. CEO of Thrive Bioscience and NSIV board member, Thomas Farb-Horch, talked about navigating through a crisis at last week’s virtual CEO seminar. Thrive Bioscience is an NSIV graduate that just closed on a $2.8M financing round.Read more
Siris Medical, Inc., a NSIV graduate company, recently announced signing a contract with Northwestern Medicine to implement the use of Siris’s InsightRTTM software. This software suite is the only Artificial Intelligence (AI) treatment decision support system for use in radiation oncology. Read the full press release here.Read more